We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSA
326
DELISTED
National Storage Affiliates Trust
NSA
$361K 0.06%
10,000
– –
REGN icon
327
Regeneron Pharmaceuticals
REGN
$79.1B
$361K 0.06%
500
– –
AIR icon
328
AAR Corp
AIR
$5.91B
$359K 0.06%
8,000
– –
PGTI
329
DELISTED
PGT, Inc.
PGTI
$359K 0.06%
20,000
– –
CHCT
330
Community Healthcare Trust
CHCT
$441M
$358K 0.06%
10,000
– –
GFF icon
331
Griffon
GFF
$4.72B
$358K 0.06%
10,000
– –
OSIS icon
332
OSI Systems
OSIS
$3.87B
$358K 0.06%
4,500
– –
NSLR
333
Neostellar Capital Corp
NSLR
$289M
$358K 0.06%
94,114
– –
MYE icon
334
Myers Industries
MYE
$1.33B
$356K 0.06%
16,000
– –
WKC icon
335
World Kinect Corp
WKC
$1.97B
$355K 0.06%
13,000
– –
ATEX icon
336
Anterix
ATEX
$1.94B
$354K 0.06%
11,000
– –
GVA icon
337
Granite Construction
GVA
$5.4B
$351K 0.06%
10,000
– –
SF
338
Stifel
SF
$12.8B
$350K 0.06%
9,000
– –
BPRN icon
339
Princeton Bancorp
BPRN
$287M
$349K 0.06%
11,000
– –
AIG icon
340
American International
AIG
$42.1B
$348K 0.06%
5,500
– –
MTCH icon
341
Match Group
MTCH
$8.9B
$347K 0.06%
8,363
– –
CYTK icon
342
Cytokinetics
CYTK
$10.7B
$344K 0.06%
7,500
– –
LMB icon
343
Limbach Holdings
LMB
$593M
$344K 0.06%
33,000
– –
EXPE icon
344
Expedia Group
EXPE
$38.4B
$339K 0.05%
3,875
– –
PBI icon
345
Pitney Bowes
PBI
$2.51B
$334K 0.05%
88,000
– –
UMBF icon
346
UMB Financial
UMBF
$11.2B
$334K 0.05%
4,000
– –
LGND icon
347
Ligand Pharmaceuticals
LGND
$6.06B
$334K 0.05%
5,000
-3,015
-38% -$196K
LIVN icon
348
LivaNova
LIVN
$4.29B
$333K 0.05%
6,000
– –
RVNC
349
DELISTED
Revance Therapeutics, Inc.
RVNC
$330K 0.05%
17,900
– –
VSH icon
350
Vishay Intertechnology
VSH
$5.09B
$325K 0.05%
15,087
– –
12 13
14
15 16

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.